title: Membrane permeation by multidrug-resistance-modulators and non-modulators: effects of hydrophobicity and electric charge.
abstract: This study was designed to test the hypothesis that lipophilic cationic drugs with only roughly similar structures mediate the reversal of multidrug-resistance (MDR) by interacting with membrane phospholipids. The permeation properties of MDR-modulators and non-modulators were studied by quantifying their ability to induce the leakage of Sulphan blue through the membrane of negatively charged unilamellar liposomes. Of the 22 compounds under investigation, only those bearing a net positive electric charge per molecule (z) > or = 0.2 induced dye leakage. All these efficient drugs are well-known MDR-modulators: calcium-channel blockers (propranolol, verapamil, diltiazem and dipyridamole), calmodulin antagonists (clomipramine and thioridazine) and antiparasitic agents (mepacrine, thioacridine derivatives and quinine). The non-modulators tested, including antineoplastic agents and steroids, did not induce any membrane permeation. The permeation process was a co-operative one (1.1 < Hill coefficient < 4.1) and the permeation doses inducing 50% dye leakage (PD50) were 1.9-11.2 mM. The permeation ability of the MDR-modulators (log(1/PD50)) increased significantly with octanol-buffer distributions per unit net electric charge ((logD)/z). The results provide evidence that a complex interplay occurs between the electric charge and the lipophilicity of the MDR-modulators when a dye leakage is induced through model membranes, and probably also when the MDR is reversed in leukaemic cells.
authors.affiliation: GERCTOP-ESA6009, Faculté de Pharmacie, Marseille, France. gerctop@pharmacie.univ.mrs.fr
authors.forename: M
authors.initials: M
authors.lastname: Castaing
authors.forename: P
authors.initials: P
authors.lastname: Brouant
authors.forename: A
authors.initials: A
authors.lastname: Loiseau
authors.forename: C
authors.initials: C
authors.lastname: Santelli-Rouvier
authors.forename: M
authors.initials: M
authors.lastname: Santelli
authors.forename: S
authors.initials: S
authors.lastname: Alibert-Franco
authors.forename: A
authors.initials: A
authors.lastname: Mahamoud
authors.forename: J
authors.initials: J
authors.lastname: Barbe
mesh_terms: D000893:Anti-Inflammatory Agents / Q000737:chemistry; D000970:Antineoplastic Agents / Q000737:chemistry; D000977:Antiparasitic Agents / Q000737:chemistry; D002021:Buffers; D002121:Calcium Channel Blockers / Q000737:chemistry; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002997:Clomipramine / Q000737:chemistry; D018432:Drug Resistance, Multiple; D008051:Lipid Bilayers / Q000737:chemistry*; D008081:Liposomes / Q000737:chemistry; D000442:Octanols; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000737:chemistry; D013256:Steroids; D013881:Thioridazine / Q000737:chemistry
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000977:Antiparasitic Agents; D002021:Buffers; D002121:Calcium Channel Blockers; D008051:Lipid Bilayers; D008081:Liposomes; D000442:Octanols; D004364:Pharmaceutical Preparations; D013256:Steroids; D013881:Thioridazine; D002997:Clomipramine